Systemic lupus erythematosus and tuberculosis: A review of complex interactions of complicated diseases

Journal of Postgraduate Medicine

Volumn 56, Issue 3, 2010, Pages 244-250

  Prabu, V N N ^a   Agrawal, S ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Extrapulmonary tuberculosis; lupus; Mycobacterium tuberculosis; pulmonary tuberculosis; systemic lupus erythematosus; tuberculosis

Indexed keywords

AMINOSALICYLIC ACID; ANTINUCLEAR ANTIBODY; BCG VACCINE; CYTOCHROME P450; ETHAMBUTOL; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; PREDNISONE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STEROID; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ASSAY; AUTOIMMUNE DISEASE; BACTERIUM CULTURE; BCG VACCINATION; BRONCHOSCOPY; CLINICAL PRACTICE; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIRECTLY OBSERVED THERAPY; DISEASE COURSE; DRUG METABOLISM; ENDEMIC DISEASE; ENZYME ACTIVITY; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INDIA; LUNG TUBERCULOSIS; LUPUS LIKE SYNDROME; MYCOBACTERIUM TUBERCULOSIS; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREVALENCE; REVIEW; RHEUMATOID ARTHRITIS; SPUTUM SMEAR; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; COMPLICATION; DRUG COMBINATION; IMMUNOCOMPROMISED PATIENT; INCIDENCE; ISOLATION AND PURIFICATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; OPPORTUNISTIC INFECTIONS;

DRUG THERAPY, COMBINATION; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INDIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTIONS; PREVALENCE; TUBERCULOSIS;

EID: 77956382535     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.68653     Document Type: Review

References (45)

1. Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus: Long-term followup of an inception cohort. Arthritis Rheum 1995;38;10:1492-1499
2. Van Ingen J, Boeree MJ, Dekhuijzen PN, van Soolingen D. Mycobacterial disease in patients with rheumatic disease. Nat Clin Pract Rheumatol 2008;4:649-656
3. Tam LS, Li EK, Wong SM, Szeto CC. Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scand J Rheumatol 2002;31:296-300.
4. Balakrishnan C, Mangat G, Mittal G, Joshi VR. Tuberculosis in patients with systemic lupus erythematosus. J Assoc Physicians India 1998;46:682-683
5. Feng PH, Tan TH. Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 1982;41:11-14
6. Pryor BD, Bologna SG, Kahl LE. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 1996;39:1475-1482
7. Noel V, Lortholary O, Casassus P, Cohen P, Genereau T, Andre MH, et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 2001;60:1141-1144
8. Paton NI, Cheong IK, Kong NC, Segasothy M. Risk factors for infection in Malaysian patients with systemic lupus erythematosus. QJM 1996;89:531-538
9. Hernandez-Cruz B, Sifuentes-Osornio J, Ponce-de-León Rosales S, Ponce-de-León Garduño A, Díaz-Jouanen E. Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases: A case-series. Clin Exp Rheumatol 1999;17:289-296
10. Global TB control: A short update to the 2009 report: WHO/HTM/TB/2009. 426.
11. Falagas ME, Voidonikola PT, Angelousi AG. Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: A review of the available evidence. Int J Antimicrob Agents 2007;30:477-486
12. Erdozain JG, Ruiz-Irastorza G, Egurbide M V, Martinez-Berriotxoa A, Aguirre C. High risk of tuberculosis in systemic lupus erythematosus. Lupus 2006;15:232-235
13. Mok MY, Lo Y, Chan TM, Wong WS, Lau CS. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. J Rheumatol 2005;32:609-615
14. Gaitonde S, Pathan E, Sule A, Mittal G, Joshi VR. Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment. Ann Rheum Dis 2002;61:251-253
15. Agrawal PN, Gupta D, Aggarval AN, Behera D. Incidence of tuberculosis among patients receiving treatment with oral corticosteroids. J Assoc Physicians India 2000;48:881-884
16. Cuchacovich R, Gedalia A. Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin North Am 2009;35:75-93.
17. Mok MY, Wong SS, Chan TM, Fong DY, Wong WS, Lau CS. Non-tuberculous mycobacterial infection in patients with systemic lupus erythematosus. Rheumatology 2007;46:280-284
18. Hou CL, Tsai YC, Chen LC, Huang JL. Tuberculosis infection in patients with systemic lupus erythematosus: Pulmonary and extra-pulmonary infection compared. Clin Rheumatol 2008;27:557-563
19. Zhang L, Wang DX, Ma L. A clinical study of tuberculosis infection in systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi 2008; 47:808-810
20. Sayarlioglu M, Inanc M, Kamali S, Cefle A, karaman O, Gul A, et al. Tuberculosis in Turkish patients with systemic lupus erythematosus: Increased frequency of extrapulmonary localization. Lupus 2004;13:274-278
21. Victorio-Navarra S T, Dy EE, Arroyo CG, Torralba T P. Tuberculosis among Filipino patients with systemic lupus erythematosus. Semin Arthritis Rheum 1996;26:628-634
22. Sousa DC, Medeiros MM. Lúpus eritematoso sistêmico etuberculose renal: Systemic lupus erythematosus and renal tuberculosis: description of nine cases. Rev Bras Reumatol 2008;48:2-6.
23. Yun JE, Lee SW, Kim TH, Jun JB, Jung S, Bae SC, et al. The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 2002;20:127-132
24. Hill HM, Kirshbaum JD. Military tuberculosis developing during prolonged cortisone therapy of systemic lupus erythematosus. Ann Intern Med 1956;44:781-790
25. Chu AD, Polesky AH, Bhatia G, Bush TM. Active and latent tuberculosis in patients with systemic lupus erythematosus living in the United States. J Clin Rheumatol 2009;15:226-229
26. Mahuad C, Bay ML, Farroni MA, Bozza V, Del Rey A, Besedovsky H, et al. Cortisol and dehydroepiandrosterone affect the response of peripheral blood mononuclear cells to mycobacterial antigens during tuberculosis. Scand J Immunol 2004;60:639-646
27. Orth T, Filippi R, Schadmand-Fischer S, Wanitschke R, Mayet WJ, Karl-Hermann, et al. Severe tuberculous meningoencephalitis in a 30 year old woman with active systemic lupus erythematosus. J Clin Rheumatol 1997;3:230-233
28. Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N, et al. Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 2008;8:24-28
29. Stephanou A, Latchman DS, Isenberg DA. The regulation of heat shock proteins and their role in systemic lupus erythematosus. Semin Arthritis Rheum 1998;28:155-162
30. Holoshitz J, Matitiau A, Cohen IR. Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest 1984;73:211-215
31. van Eden U, Holoshitz J, Nevo Z, Frenkel A, Klagman A, Cohen IR. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci 1985;82:5117-5120
32. Ghosh K, Patwardhan M, Pradhan V. Mycobacterium tuberculosis infection precipitates SLE in patients from endemic areas. Rheumatol Int 2009;29:1047-1050
33. Purice S, Mitu S, Popescu T, Guran M, Vintil M, Su G. The relationship between systemic lupus erythematosus and tuberculosis. Med Interne 1982;20:191-196
34. Targeted tuberculin testing and treatment of latent tuberculosis infection: This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999: This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC): This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000;161:S221-47.
35. Rivera V, Chavez N, Carranza I, Fuentes I, Portela M, Moreno J et al. Prevalence of skin reactivity to tuberculin in patients with rheumatoid arthritis [RA] and systemic lupus erythematosus [SLE]. American College of Rheumatology 2004 meeting; October 16-21, 2004; San Antonio, TX; Abstract 197.
36. Mishra O P, Yusaf S, Ali Z, Nath G, Das BK. Adenosine deaminase activity and lysozyme levels in children with tuberculosis. J Trop Pediatr 2000;46:175-178
37. Pettersson T, Klockars M, Weber T. Pleural fluid adenosine deaminase in rheumatoid arthritis and systemic lupus erythematosus. Chest 1984;86:273-274
38. Ungerer J P, Oosthuizen HM, Retief JH, Bissbort SH. Significance of adenosine deaminase activity and its isoenzymes in tuberculous effusions. Chest 1994;106:33-37
39. Taysi S, Polat M F, Sari RA, Bakan E. Serum adenosine deaminase and cytidine deaminase activities in patients with systemic lupus erythematosus. Clin Chem Lab Med 2002;40:493-495
40. Lalvani A, Millington KA. Screening for tuberculosis infection prior to initiation of anti-TNF therapy. Autoimmun Rev 2008;8:147-152
41. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167:603-662
42. th ed. London: Pharmaceutical Press; 2008.
43. Rothfield N F, Bierer W F, Garfield JW. Isoniazid induction of antinuclear antibodies: A prospective study. Ann Intern Med 1978;88:650-652
44. Andonopoulos A P, Safridi C, Karokis D, Bounas A. Is a purified protein derivative skin test and subsequent antituberculous chemoprophylaxis really necessary in systemic rheumatic disease patients receiving corticosteroids Clin Rheumatol 1998;17:181-185
45. Kim HY, Im JG, Goo JM, Lee JK, Song JW, Kim SK. Pulmonary tuberculosis in patients with systemic lupus erythematosus. AJR Am J Roentgenol 1999;173:1639-1642